A patient with BMI 25.5 who has tried multiple diets, has prediabetes, and wants to prevent progression to diabetes is a reasonable candidate for compounded tirzepatide even though they fall slightly below FDA approval criteria

But Ro weight loss offerings may be especially helpful for people who: Have a qualifying body mass index (BMI) and are looking for clinically guided weight loss support Are interested in GLP-1 medications like Wegovy, Zepbound, Foundayo, or Ozempic and want help navigating access and eligibility Prefer a fully online experience with no in-person appointments, long waits, or pharmacy confusion Want support beyond medication, including monthly check-ins, unlimited messaging with providers, and access to health coaching Need help navigating insurance, prior authorizations, or cost-saving options for GLP-1 medication Are seeking a long-term, habit-focused approach not a quick fix Whether this is your first attempt at weight loss or the next stage in a lifelong journey, taking the step toward effective, lasting success can be intimidating
For some people, especially those carrying significant extra bodyweight, these medications can be incredibly helpful
Tirzepatide, a dual GLP-1 and GIP receptor agonist, significantly reduces body weight in clinical trialsbut questions about emotional side effects remain common
Reconstitution and preparation checklist Getting the preparation right is fundamental